Propranolol response in patients with segmental versus focal facial hemangiomas: A retrospective case-control study - 16/07/22
Doi : 10.1016/j.jaad.2021.10.054
Florian Schmid, MD a, Peter H. Hoeger, MD a, b, ⁎ 
a Department of Pediatrics, Catholic Children's Hospital Wilhelmstift, Hamburg, Germany
b Department of Pediatric Dermatology, Catholic Children's Hospital Wilhelmstift, Hamburg, Germany
∗Correspondence to: Peter H. Hoeger, MD, Departments of Pediatrics and Pediatric Dermatology, Catholic Children's Hospital Wilhelmstift, Liliencronstrasse 130, Hamburg 22143, GermanyDepartments of Pediatrics and Pediatric DermatologyCatholic Children's Hospital WilhelmstiftLiliencronstrasse 130Hamburg22143Germany
| Funding sources: None. |
|
| IRB status: Not applicable. |
|
| Key words: oral propranolol treatment; PHACE (posterior fossa malformations; hemangiomas; arterial anomalies; cardiac defects; eye abnormalities) syndrome; relapse rate; segmental hemangioma. |
|
| Reprints not available from the authors. |
© 2021
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 87 - N° 2
P. 490-491 - août 2022 Retour au numéro
Article précédent
- Bicalutamide improves minoxidil-induced hypertrichosis in female pattern hair loss: A retrospective review of 35 patients
- Anthony Moussa, Ahmed Kazmi, Laita Bokhari, Rodney D. Sinclair
- Dermatologic surgery opioid prescribing recommendations in practice
- Surya A. Veerabagu, Arianna F. Yanes, Brian Cheng, Jeremy R. Etzkorn, Christopher J. Miller, Thuzar M. Shin, Joseph F. Sobanko, H. William Higgins, Stacy L. McMurray, Joanna L. Walker, Cerrene N. Giordano
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?